Contact l Sitemap

home industries issues reasearch weblog press

Home  » Issues » World Financial Institutions

UN: African Leaders Say Debt Hampers Fight Against AIDS

by Lewis MachipisaInter Press Service
June 25th, 2001

UNITED NATIONS -- African leaders used the opening of the UN General Assembly Special Session on HIV-AIDS Monday to assail the international community's response to the deadly epidemic for failing to match the speed and seriousness with which the disease is infecting their citizens.

Official after official rose to drive home the message that the death of more than 20 million people, mostly in sub-Saharan Africa, demands that more money be committed to the fight.

''If we all act decisively, we can redeem ourselves," Botswana President Festus Mogae implored the high-level gathering.

"If resolute and concerted action is not taken against the spread of HIV/AIDS, the human death toll and suffering that will be inflicted will be catastrophic," Mogae warned.

Nigerian President Olusegun Obasanjo lamented that "Africa, a continent already crippled with problems of underdevelopment, poverty, food scarcity, internal conflicts and the heavy burden of external debt, is the hardest hit by the HIV-AIDS pandemic.''

''Africa must survive," Obasanjo declared.

UNAIDS, the UN agency coordinating the world body's response to the pandemic, estimates that 25.3 million people in sub-Saharan Africa are living with HIV-AIDS, out of a worldwide total of 36.1 million.

Anti-retroviral drugs are being touted as the most effective treatment for those already infected and African delegates said secure access at lower prices was a top priority. Many also scored the disappointing international response to UN Secretary-General Kofi Annan's call for between seven billion and ten billion dollars per year for a global fund to fight AIDS and other health threats.

By the time the UN talks end on Wednesday, the fund is unlikely to have garnered more than one billion dollars in firm pledges, officials warned.

Uganda, a pioneer in AIDS control efforts since the 1980s, has pledged two million dollars to the fund. Ugandan officials said they know this is too little to make a serious impact and exhorted richer countries to "contribute according to what is proportionate to their resources."

Even if fully financed, the fund will remain dwarfed by Africa's burden of debt, officials and activists said.

Sub-Saharan African countries pay 14.2 billion dollars each year to their foreign creditors, including governments, multilateral lenders including the World Bank and International Monetary Fund, and private banks, according to the non-governmental organisation (NGO) Drop the Debt.

The US pledge to Annan's fund -- 200 million dollars -- is equivalent to less than a week's debt servicing.

Drawing on such statistics, some African delegates pressed for not only increased spending on health but also the cancellation of foreign debt so the resulting gains could be used to subsidise life-saving treatments and offset the economic impact of HIV-AIDS.

''The circumstance and the situation of HIV-AIDS underscore our call for total cancellation of Africa's debts in favour of investment in the social sector. If we are to be true partners in development, the debt issue must be addressed in a comprehensive manner that frees our resources to enable us fight the scourge of HIV-AIDS,'' Obasanjo insisted.

''African countries need access to long-term international financing arrangements in order to have viable sustained economic growth, generate adequate resources and build capacities for poverty eradication and combating HIV-AIDS, including total debt cancellation for poor and highly-indebted countries,'' added Eriya Kategaya, Uganda's deputy prime minister.

African delegates noted that Zambia, which is pitifully poor and where one fifth of all adults have HIV, spends 100 million dollars more on debt payments than on health. African leaders pressed their demands for debt cancellation at a summit in Abuja, Nigeria, in April but to their consternation, wealthy countries and multilateral lenders have balked at decisive action.

Meanwhile, the human and economic costs soar. Between 1990 and 1997, Africa's per capita income growth was reduced from 1.1 percent to 0.4 percent as a result of HIV-AIDS, according to the World Bank. Kenya's GDP will be 15 percent lower in 2005 than it would have been if the spread of HIV-AIDS had been curtailed.

Jacques Diouf, director-general of the UN's Food and Agricultural Organisation, said the cost of caring for a patient and meeting the subsequent funeral expenses exceeds the average African farmer's annual income.

According to Annan, AIDS, combined with underlying economic woes, is reversing southern African gains in life expectancy. The average child born between 2002 and 2010 likely will die before reaching 45 years of age - compared to 58 years now.

Already, children younger than five account for one in every four African AIDS deaths, according to World Vision, an NGO. There are already 13 million AIDS orphans on the continent and, in the absence of significant intervention, the number will rise to 30 million by 2010, the group warned.

By then, it added, the cost of training replacements for the 14,460 teachers expected to die from HIV-AIDS in Tanzania alone will reach 21 million dollars.

Despite the urgency of their needs, African leaders have had to temper their demands for fear of alienating the wealthy nations that are the inevitable sources of most of the money that will be needed.

Kenya's President Daniel arap Moi appeared to capture their dilemma Monday. ''We are not a wealthy nation, but my people must at least be given hope," he said.

''The time has come when we are compelled to make a decision between the lives of our people and the right of commercial interest. Human life must surely come before anything else,'' Moi said in an apparent reference to Western drug makers who oppose poor countries' efforts to manufacture generic AIDS drugs at a small fraction of the prices charged by the multinational firms. "Our choice is therefore made."

The manufacturers of brand name drugs have argued, among other things, that competition from cheaper products is squeezing their profit margins and will limit their research budgets.

Faced with an argument that amounts to an ultimatum made by the firms and repeated by US and other delegates from the companies' home countries, Moi added: ''Nonetheless, we must pursue our choice in a balanced way, balanced to protect the interests of further research and development so that life can be further protected and enhanced.''





This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.